PE-22-28peptide The dominant search intent for "pe-22 peptide" appears to be informational, focusing on understanding what the peptide is, its mechanisms of action, potential benefits, and current research status, particularly concerning its role as a TREK-1 inhibitor and its implications for depression and neurological health.
Tier 1:
* Core Entity: PE-22-28 peptide
* Key Function/Mechanism: TREK-1 inhibitor, potential to mitigate depression, neurogenesis, synaptogenesis
* Related Entity: Spadin (natural precursor/analogue)
* High-Relevance Phrases: PE-22-28 peptide, TREK-1 inhibitor, potential to mitigate depression, neurogenesis, synaptogenesis
Tier 2:
* Attributes: Short peptide, 7 amino acids, synthetic derivative, IC50 value (0PE 22-28 (4 µg/kg for four days) increases neurogenesis and the levels of postsynaptic density protein 95 (Psd-95), a measure of increased synaptogenesis, in ....12 nM), research peptide, not FDA-approved
* Related Concepts: Spadin analogs, mini-spadin, stroke recovery, cognitive health, neuroinflammation, oxidative stress
* Variations: PE 22-28, PE 22
Tier 3:
* Specific dosages (unless presented as general information), supplier names, purchase-related terms (unless integrated into context), repetitive mentions of "peptide" or "peptides" without specific context, CAS numbers, overly specific research paper details not central to the peptide's function.
---
The PE-22-28 peptide is a subject of growing interest within the scientific community, particularly for its potential applications in neurological health and mood regulation. As a synthetic derivative of the naturally occurring peptide spadin, PE-22-28 has emerged as a potent TREK-1 inhibitor, a mechanism that underpins its observed effects on depression and neurogenesis.Shortened Spadin Analogs Display Better TREK-1 Inhibition ... Research suggests that PE-22-28 holds significant promise for mitigating depressive symptoms and enhancing cognitive functions, positioning it as a key area of exploration in neuroscienceThe Potential of PE-22-28 Peptide in Biochemical and ....
PE-22-28 is a peptide, a short chain of amino acids that are the fundamental building blocks of proteins. Specifically, PE-22-28 is often described as a 7 amino-acid peptide, derived from or related to spadinPE-22-28 (10mg Vial) Dosage Protocol. Spadin itself is a 17-amino acid peptide initially identified for its role in depression research. PE-22-28 is a synthetic analogue that has demonstrated enhanced efficacy and stability, making it a valuable tool for scientific investigation.PE-22-28 has shown potential in reducing neuroinflammation and oxidative stress, factors that are often linked to cognitive decline and neurological conditions. Its development as a "mini-spadin" analog highlights efforts to create more targeted and potent versions of naturally occurring peptides for therapeutic research.
A primary characteristic of the PE-22-28 peptide is its function as a TREK-1 inhibitor. TREK-1 (Potassium channel subfamily K member 2) is a type of potassium channel found in neurons that plays a role in regulating neuronal excitability and synaptic plasticity. By inhibiting TREK-1 channels, PE-22-28 can influence neuronal firing patterns and potentially restore balance in brain circuits implicated in mood disorders. The high potency of PE-22-28 as a TREK-1 inhibitor is often quantified by its IC50 value, which for PE-22-28 is reported to be as low as 0.12 nM, indicating a strong binding affinity and effective blockage of the channelThe syntheticpeptide PE-22-28 represents a promising avenue for advancing research in cellular signaling, stress response, and molecular interactions. Its .... This targeted inhibition is crucial for its observed effects on the central nervous system.
The research surrounding PE-22-28 points to several potential benefits, primarily centered on neurological health and mood management.
* Depression Mitigation: One of the most consistently highlighted potentials of PE-22-28 is its ability to mitigate symptoms of depression.2024年11月27日—PE-22-28 is a peptide fragment derived from the melanin-concentrating hormone(MCH), a neuropeptide initially regarded by scientists for its ... Studies suggest a rapid onset of action, potentially offering relief within days, and in some cases, outperforming traditional antidepressant medications in preclinical models. This effect is linked to its modulation of neuronal activity and its impact on neurogenesis.
* Neurogenesis and Synaptogenesis: PE-22-28 has shown the capacity to upregulate neurogenesis, the process by which new neurons are generated in the brain, and synaptogenesis, the formation of new synapses between neurons. These processes are vital for learning, memory, and overall brain plasticity. By promoting these functions, PE-22-28 could offer therapeutic avenues for cognitive decline and neurological damage2025年4月30日—Wuhan Newtop Biotech Co., Ltd is a professional chemical raw materials andpeptidesmanufacturer with many years experince,Our factory has ....
* Stroke Recovery and Neuroprotection: Preclinical studies in rodent models of ischemia (stroke) have indicated that PE-22-28 can reduce apoptotic cell death, suggesting a protective effect on brain tissue during and after stroke eventsPE-22-28 (Spadin), offered at 5mg, is a high-quality specialised research peptide developed for advanced scientific exploration in neuroscience and related .... This neuroprotective quality, combined with its impact on neurogenesis, makes it a candidate for research into stroke recovery strategies.
* Reducing Neuroinflammation and Oxidative Stress: Emerging research also suggests that PE-22-28 may play a role in reducing neuroinflammation and oxidative stress, factors commonly associated with the progression of neurological conditions and cognitive impairmentPeptide PE-22-28 - BluVida Wellness & Med Spa.
It is important to note that PE-22-28 is currently considered a research peptidePE-22-28 (10mg). This means that while preclinical studies show promising results, it has not yet received FDA approval for human use, and no human clinical trials have been published中文名称：:PE 22-28 peptide. 英文名称：: PE 22-28 peptide. CAS号：: 97145-43-2. 纯度规格：: >98%.. Information regarding its efficacy and safety is derived from laboratory and animal studies. Therefore, any exploration of its use should be approached with caution and ideally under the guidance of qualified medical professionals who are knowledgeable about peptide research. The "peptide therapy" context often surrounding PE-22-28 underscores its experimental nature, with dosage protocols and administration methods still being explored in research settings.
In conclusion, the PE-22-28 peptide represents a compelling area of research in neuroscience2024年11月27日—PE-22-28 is a peptide fragment derived from the melanin-concentrating hormone(MCH), a neuropeptide initially regarded by scientists for its .... Its potent TREK-1 inhibitory activity forms the basis for its potential to address depression, enhance neurogenesis, and offer neuroprotection. As research progresses, a clearer understanding of its therapeutic applications and safety profile will undoubtedly emerge, further illuminating the role of targeted peptide interventions in brain healthThe chart below shows various dosing options coupled with the amount (in mg) and frequency for each dose. Dosing should be determined by the physician on an ....
Join the newsletter to receive news, updates, new products and freebies in your inbox.